Clinical Trials Browser

Unknown × Recurrence × nintedanib × Clear all

NCT02558387 2015-11-20

Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck

Phase 2 Unknown

Recurrence